Related Experiment Video

Updated: Jul 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The effect of intensive lipid lowering on coronary atheroma and clinical outcome

Emma S Houslay, Jaydeep Sarma, Neal G Uren

    Heart (British Cardiac Society)
    |October 13, 2006
    PubMed

    Insights

    Intensive cholesterol lowering reduces cardiovascular events. However, the exact benefit of further lowering LDL-cholesterol below certain thresholds remains unclear for clinical outcomes.

    Area of Science:

    • Cardiovascular Medicine
    • Lipid Metabolism
    • Atherosclerosis Research

    Background:

    • Established link between high cholesterol and cardiovascular disease (CVD).
    • LDL-cholesterol reduction is proven to decrease cardiovascular events.
    • Intensive lipid lowering is hypothesized to stabilize atherosclerotic plaques.

    Discussion:

    • Investigating the clinical benefits of intensive lipid lowering.
    • Examining potential plaque stabilization and reduced vulnerability.
    • Assessing if continued clinical benefit occurs with intensive lipid lowering.

    Key Insights:

    • Consistent evidence supports LDL-cholesterol reduction for cardiovascular event prevention.
    • Hypothesis that intensive lipid lowering offers additional benefits beyond plaque stabilization.
    • Uncertainty regarding continued clinical benefit or a threshold effect.

    Outlook:

    • Further research needed to determine optimal LDL-cholesterol targets.
    • Clarifying the relationship between intensive lipid lowering and clinical outcomes.
    • Understanding the threshold for maximal cardiovascular risk reduction.

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Atherosclerosis I: Introduction01:30

    Atherosclerosis I: Introduction

    Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
    Inflammation01:38

    Inflammation

    Overview
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...